Embeline e and Irritable bowel syndrome - a phase IV clinical study of FDA data

Summary:

Irritable bowel syndrome is reported as a side effect among people who take Embeline e (clobetasol propionate), especially for people who are female, 20-29 old, also take Penlac,.

The phase IV clinical study analyzes which people have Irritable bowel syndrome when taking Embeline e. It is created by eHealthMe based on reports of 37 people who have side effects when taking Embeline e from the FDA, and is updated regularly.

What is Embeline e?

Embeline e has active ingredients of clobetasol propionate. eHealthMe is studying from 37 Embeline e users. Check the latest studies of Embeline e.

What is Irritable bowel syndrome?

Irritable bowel syndrome is found to be associated with 1,316 drugs and 2,128 conditions by eHealthMe. Check the latest studies of Irritable bowel syndrome.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 02, 2026

37 people reported to have side effects when taking Embeline e.
Among them, 17 people (45.95%) have Irritable bowel syndrome.

Could Embeline e cause Irritable bowel syndrome?

Among these 17 people:

What is the gender of people who have Irritable bowel syndrome when taking Embeline e? *

female: 100 %
male: 0.0 %

What is the age of people who have Irritable bowel syndrome when taking Embeline e? *

What are other drugs people take besides Embeline e? *

What are other side effects people have besides Irritable bowel syndrome? *

Abdominal Pain: 17 people, 100.00%
Inflammatory Bowel Disease: 17 people, 100.00%
Hepatic Enzyme Increased: 17 people, 100.00%
Gastroenteritis (inflammation of stomach and intestine): 17 people, 100.00%
Hepatitis (inflammation of the liver): 17 people, 100.00%
Fatigue (feeling of tiredness): 17 people, 100.00%
High Blood Pressure: 17 people, 100.00%
Dry Skin: 17 people, 100.00%
Hypertensive Crisis: 17 people, 100.00%
Hypertriglyceridaemia (excess of triglycerides in the blood): 17 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Embeline e and have Irritable bowel syndrome?

- Check whether Irritable bowel syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embeline e:

Embeline e (37 reports)

Browse all side effects of Embeline e:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Irritable bowel syndrome:

Irritable bowel syndrome (1,316 drugs)

Browse all the conditions that are associated with Irritable bowel syndrome:

Irritable bowel syndrome (2,128 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clobetasol propionate (the active ingredients of Embeline e) and Embeline e (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.